Idiopathic generalised epilepsies with 3 Hz and faster spike wave discharges: A population-based study with evaluation and long-term follow-up in 71 patients

Epileptic Disorders

Volumn 4, Issue 3, 2002, Pages 209-216

  Siren, Auli ^a,b   Eriksson, Kai ^a,c   Jalava, Heli ^a   Kilpinen Loisa, Päivi ^a   Koivikko, Matti ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b ERASME HOSPITAL   (Belgium)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Idiopathic generalised epilepsy; Intractable seizures; Long term follow up

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ABSENCE; ADOLESCENT; ADULT; ARTICLE; BLINKING; CHILDHOOD; CONTROLLED STUDY; DISEASE CONTROL; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; FEMALE; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; IDIOPATHIC DISEASE; INTERVIEW; JUVENILE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MONOTHERAPY; MYOCLONUS EPILEPSY; ONSET AGE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SEIZURE; SPIKE WAVE; TONIC CLONIC SEIZURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLINKING; CHILD; ELECTROENCEPHALOGRAPHY; EPILEPSY, TONIC-CLONIC; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; POPULATION SURVEILLANCE; SEVERITY OF ILLNESS INDEX;

EID: 0036762487     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Commission on classification and terminology of the international league against epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.
2. Gordon N, Aird RB. "Idiopathic childhood absences", a system disorder: It's diagnosis and differentiation. Dev Med Child Neurol 1991; 33: 744-8.
3. Commission on epidemiology and prognosis, international league against epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993; 34: 592-6.
4. Berkovic SF, Reutens D, Andermann E, Andermann F. The epilepsies: Specific syndromes or a neurobiological continuum? In: Wolf P. Epileptic Seizures and Syndromes. London: John Libbey & Company Ltd, 1994: 25-37.
5. Reutens DC, Berkovic SF. Idiopathic generalized epilepsy of adolescence: Are the syndromes clinically distinct? Neurology 1995; 45: 1469-76.
6. Sillanpää M, Jalava M, Kaleva O, et al. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998; 338: 1715-22.
7. Lerman P. Benign partial epilepsy with centro-temporal spikes. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P. Epileptic syndromes in infancy, childhood and adolescence (2nd ed.). London: John Libbey, 1992: 198-200.
8. Olsson I, Hagberg G. Epidemiology of absence epilepsy. Acta Paediatr Scand 1991; 80: 1066-72.
9. Wirrel E, Camfield C, Camfield P, Dooley J. Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy. Epilepsia 2001; 42: 760-3.
10. Wirrell EC, Camfield CS, Camfield PR, et al. Long-term prognosis of typical childhood absence epilepsy: Remission or progression to juvenile myoclonic epilepsy. Neurology 1996; 47: 912-8.
11. Kleveland G, Engelsen BA. Juvenile myoclonic epilepsy: Clinical characteristics, treatment and prognosis in a Norwegian population of patients. Seizure 1998; 7: 3-8.
12. Penry KJ, Dean C, Riela AR. Juvenile myoclonic epilepsy: Long-term response to therapy. Epilepsia 1989; 30 (suppl 4): S19-23.
13. Loiseau P, Pestre M, Dartigues F, et al. Long-term prognosis in two forms of childhood epilepsy: Typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann Neurol 1983; 13: 642-8.
14. Sato S, Dreifuss FE, Penry KF, et al. Long-term follow-up of absence seizures. Neurology 1983; 33: 1590-5.
15. Gastaut H, Zifkin BG, Mariani E, et al. The long-term course of primary generalized epilepsy with persisting absences. Neurology 1986; 36: 1021-8.
16. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-9.
17. Janz D, Durner M. Juvenile myoclonic epilepsy. In: Engel J, Jr, Pedley TA. Epilepsy. A Comprehensive Textbook. Philadelphia, New York: Lippincott-Raven 1997: 2389.
18. Leppik IE. How to get patients with epilepsy to take their medication. The problem of noncompliance. Postgrad Med 1990; 88: 253-6.
19. Potschka H, Fedrowitz M, Loscher W. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 2001; 12: 3557-60.
20. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. PNAS 2000; 97: 3473-8.
21. Gericke CA, Picard F, de Saint-Martin A, et al. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: A video-EEG-controlled, open study. Epileptic Disord 1999; 1: 159-65.
22. Buchanan N. The use of lamotrigine in juvenile myoclonic epilepsy. Seizure 1996; 5: 149-51.
23. Calleja S, Salas-Puig J, Ribacoba R, Lahoz CH. Evolution of myoclonic epilepsy treated from the outset with sodium valproate. Seizure 2001; 10: 424-7.
24. Giannakodimos S, Panayiotopoulos CP. Eyelid myoclonia with absences in adults: A clinical and video-EEG study. Epilepsia 1996; 37: 36-44.
25. Capovilla G, Rubboli G, Beccaria F, et al. A clinical spetcrum of the myoclonic manifestations associated with typical absences in childhood absence epilepsy. A video-polygraphic study. Epileptic Disord 2001; 3: 57-62.
26. Obeid T. Clinical and genetic aspects of juvenile absence epilepsy. J Neurol 1994; 241: 487-91.
27. Panayiotopoulos CP, Chroni E, Daskapoulos C, et al. Typical absence seizures in adults: Clinical, EEG, video-EEG findings and diagnostic/syndromic considerations. J Neurol Neurosurg Psychiatry 1992; 55: 1002-8.
28. Loiseau P, Duche B, Pédespan JM. Absence épilepsies. Epilepsia 1995; 36: 1182-6.
29. Olsson I. Epidemiology of absence epilepsy. I. Concept and incidence. Acta Paediatr Scand 1988; 77: 860-6.
30. Janz D. Die Epilepsien. Stuttgart: Georg Thieme Verlag, 1969.
31. Janz D. The idiopathic generalized epilepsies of adolescence with childhood and juvenile age of onset. Epilepsia 1997; 38: 4-11.
32. Wolf P. Juvenile myoclonic epilepsy. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P. Epileptic Syndromes in Infancy, Childhood and Adolescence (2nd Ed.). London: John Libbey, 1992: 313-27.
33. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: A 5-year prospective study. Epilepsia 1994; 35: 285-96.
34. Rocca WA, Sharbrough FW, Hauser WA, et al. Risk factors for absence seizures: A population-based case-control study in Rochester, Minnesota. Neurology 1987; 37: 1309-14.
35. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120: 479-90.
36. +-channel beta1 subunit gene SCN1B. Nat Genet 1998; 19: 366-70.
37. Escayg A, Baulac S, Moulard B, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000; 24: 343-5.
38. Wallace RH, Marini C, Petrou S. Mutant GABAA receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001; 28: 49-52.
39. Labuda M, Siren A, Bourgoin S, et al. Genetic study of generalized and partial epilepsy - Linkage on chromosome 5. Am J Hum Gen 2000; 67 (suppl 2): 340.